Related Experiment Video
Updated: Jul 6, 2026

The Utility of Stage-specific Mid-to-late Drosophila Follicle Isolation
Published on: December 2, 2013
Identification and characterization of a novel folliculin-interacting protein FNIP2
Hisashi Hasumi1, Masaya Baba, Seung-Beom Hong
1Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20894, United States.
Abstract:
Birt-Hogg-Dube' syndrome characterized by increased risk for renal neoplasia is caused by germline mutations in the BHD/FLCN gene encoding a novel tumor suppressor protein, folliculin(FLCN), which interacts with FNIP1 and 5'-AMP-activated protein kinase(AMPK). Here we report the identification and characterization of a novel FNIP1 homolog FNIP2 that also interacts with FLCN and AMPK. C-terminally-deleted FLCN mutants, similar to those produced by naturally-occurring germline mutations in BHD patients, were unable to bind FNIP2. These data taken together with our previous results that demonstrated FNIP1 binding to the C-terminus of FLCN suggest that FLCN tumor suppressor function may be facilitated by interactions with both FNIP1 and FNIP2 through its C-terminus. Furthermore, we demonstrate that FNIP1 and FNIP2 are able to form homo- or heteromeric multimers suggesting that they may function independently or cooperatively with FLCN. Differential expression of FNIP1 and FNIP2 transcripts in some normal tissues may indicate tissue specificity for these homologs. Interestingly FNIP1 and FNIP2 were oppositely expressed in human clear cell renal cell carcinoma (RCC), and coordinately expressed in chromophobe RCC and oncocytoma, suggesting their differential function in different histologic variants of RCC.
Insights
Researchers identified FNIP2, a novel protein interacting with FLCN, crucial for tumor suppression in Birt-Hogg-Dube syndrome. This discovery sheds light on renal cancer mechanisms and potential therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Birt-Hogg-Dube syndrome involves germline mutations in the BHD/FLCN gene, increasing renal neoplasia risk.
- Folliculin (FLCN) is a tumor suppressor protein interacting with FNIP1 and AMPK.
Purpose of the Study:
- Identify and characterize novel FLCN-interacting proteins.
- Investigate the role of these interactions in FLCN tumor suppressor function.
- Explore the differential expression of FNIP1 and FNIP2 in renal cell carcinoma.
Main Methods:
- Protein interaction assays to identify FNIP2 binding to FLCN and AMPK.
- Analysis of FLCN mutants to assess FNIP2 binding.
- Quantitative analysis of FNIP1 and FNIP2 transcript expression in normal tissues and renal tumors.
Main Results:
- A novel FNIP1 homolog, FNIP2, was identified and shown to interact with FLCN and AMPK.
- FLCN mutants associated with Birt-Hogg-Dube syndrome failed to bind FNIP2.
- FNIP1 and FNIP2 can form homo- and heteromeric multimers.
- Opposite expression of FNIP1 and FNIP2 in clear cell renal cell carcinoma; coordinate expression in other RCC subtypes.
Conclusions:
- FLCN's tumor suppressor function is likely mediated by interactions with both FNIP1 and FNIP2 via its C-terminus.
- FNIP1 and FNIP2 may function independently or cooperatively with FLCN.
- Differential expression patterns suggest distinct roles for FNIP1 and FNIP2 in various renal cell carcinoma subtypes.
More Related Videos
Related Concept Videos
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
piRNA - Piwi-interacting RNAs

